Skip to main content

Closed

ZYME: Zymeworks Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.4% / yr

Operating margin-140.4%

ROIC-25.3%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage-55.2×

Current ratio10.82×

Zymeworks Inc.

ZYMENASDAQ Global Select·USD·Closed

Zymeworks Inc.

ZYMENASDAQ·USD·Closed

$21.94

−3.39%

$21.94

−$0.77 (3.39%)

52W Range

57thpctl

Volume

0.60×avg

Mkt Cap

1.61BUSD

P/E

-16.0TTM

Div Yield

–ann

52W Range

57thpctl

Volume

0.60×avg

Market Cap

1.61BUSD

P/E Ratio

-16.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings